The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
about
Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activityTenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionHow HIV takes advantage of the cytoskeleton in entry and replicationRole of heparan sulfate in sexually transmitted infectionsLignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmissionA Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 UpregulationSulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug DiscoveryCurrent concepts regarding the HTLV-1 receptor complex.Shiga-like toxins and HIV-1 'go through' glycosphingolipids and lipid rafts in renal cells.Identification of heparin-binding sites in proteins by selective labeling.Human erythrocytes selectively bind and enrich infectious HIV-1 virions.Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells.Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albuminsMapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomeraseA whole genome association study of mother-to-child transmission of HIV in Malawi.Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokinesCirculating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheetMolecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsInhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionalityPolyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge.Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.Microbial heparin/heparan sulphate lyases: potential and applications.Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.New targets for glycosaminoglycans and glycosaminoglycans as novel targets.Bridging the past and the future of virology: surface plasmon resonance as a powerful tool to investigate virus/host interactions.Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1.HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.Glycosaminoglycans as regulators of stem cell differentiation.Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120.Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate
P2860
Q21562543-F1C63838-48ED-4201-91AA-02532382DFFCQ24598653-A31F7806-5358-4471-8670-1CD9A9B8C1CDQ27004059-CC5C197F-3285-43A6-8D79-C99144F3653CQ27021639-18125969-F845-4AE2-9ACC-F5B16A2C146EQ27023959-AF047118-643D-4BE7-8DD7-975D80B3C5C9Q28482818-59137915-A7CA-43DF-8301-32372E38FDE1Q28553032-24E0D519-B5A3-4B9D-A760-80DD0F46BE05Q28817653-38CF0898-5742-4C89-9EA1-9C97366A60E7Q33350169-2834411F-81FF-4FEB-92DD-9C9B2E6901E9Q33384511-BCD0E0C2-8F1B-43E2-BBD2-B9197A0C4CC2Q33476610-D6C94245-76F4-463D-A7D6-9BD8A0BFA794Q33518534-D65EA96A-9771-490A-8B24-299E2BD1C31EQ33591038-17B72176-364B-4938-9D20-99075D0223FAQ33594858-2FB5D620-B520-4738-997D-C5E7A69DB7C8Q33810106-3E5AA385-9F02-46B6-9292-B6FF77E3454CQ33865715-B6FCD4C9-7B7E-410E-BF75-340084264A52Q35111062-73B2D691-7150-4C62-B283-15C699DBEC89Q35619297-1E742B3B-952B-41DF-B750-EBCF3200307EQ35994961-3C4BF43E-D489-457F-A583-99A42244F3D6Q36057328-FD7183E6-F7B3-4343-920F-BBA1708C1471Q36526260-34A01839-050D-4F62-A6EF-18A59BEDB5BBQ37300431-AB9929D8-B03F-4609-A75F-9CE3F7FE88A1Q37305864-DF22A3D1-C0CD-45F2-A3F7-71E10DC09D8FQ37323266-4EBE74A8-A82C-4F3D-80A1-6FF96C0C4009Q37323948-DC004F3E-4D6F-4BB2-AD66-DCA13CD611B0Q37415434-7F368141-EC2B-4E29-BCD0-2AF023B6036FQ37990767-E6571CA0-7862-4F9C-B66D-ABB4E32E4978Q38001955-C23BCF71-9405-489E-AAD0-5E4E9C7C7CD3Q38081956-9CEF5324-328C-4C4B-A995-D1502C5F9366Q38141148-FCE0C7DE-77DC-451B-BD81-557D719BECAEQ38305855-C73BE6E0-14C7-42D9-BA6E-A103648DB85CQ38953557-CFD0B9ED-EB0B-4747-9A09-B2F0DBC45002Q39115158-51498450-7501-41B8-9341-6EA03770DE45Q39603105-052DA55C-636D-4E33-9B81-1E7EB817B55EQ42268696-12058F73-1D1F-4C36-B210-749B7ACC81AFQ57079901-0DB54FA8-7F8F-4933-B888-8D1D926092F1
P2860
The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@ast
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@en
type
label
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@ast
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@en
prefLabel
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@ast
The HIV-1 envelope glycoprotei ...... the co-receptor binding site.
@en
P2093
P2860
P356
P1476
The HIV-1 envelope glycoprotei ...... g the co-receptor binding site
@en
P2093
Elodie Crublet
Hugues Lortat-Jacob
Jean-Pierre Andrieu
P2860
P304
15193-15200
P356
10.1074/JBC.M800066200
P407
P50
P577
2008-03-31T00:00:00Z